SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia

SWI/SNF is an evolutionarily conserved multi-subunit chromatin remodeling complex that regulates epigenetic architecture and cellular identity. Although SWI/SNF genes are altered in approximately 25% of human malignancies, evidences showing their involvement in tumor cell–autonomous chromatin regulation and transcriptional plasticity are limiting. This study demonstrates that human primary acute myeloid leukemia (AML) cells exhibit near complete loss of SMARCB1 (BAF47 or SNF5/INI1) and SMARCD2 (BAF60B) associated with nucleation of SWI/SNFΔ. SMARCC1 (BAF155), an intact core component of SWI/SNFΔ, colocalized with H3K27Ac to target oncogenic loci in primary AML cells. Interestingly, gene ontology (GO) term and pathway analysis suggested that SMARCC1 occupancy was enriched on genes regulating Rac GTPase activation, cell trafficking, and AML-associated transcriptional dysregulation. Transcriptome profiling revealed that expression of these genes is upregulated in primary AML blasts, and loss-of-function studies confirmed transcriptional regulation of Rac GTPase guanine nucleotide exchange factors (GEF) by SMARCB1. Mechanistically, loss of SMARCB1 increased recruitment of SWI/SNFΔ and associated histone acetyltransferases (HAT) to target loci, thereby promoting H3K27Ac and gene expression. Together, SMARCB1 deficiency induced GEFs for Rac GTPase activation and augmented AML cell migration and survival. Collectively, these findings highlight tumor suppressor role of SMARCB1 and illustrate SWI/SNFΔ function in maintaining an oncogenic gene expression program in AML. Implications: Loss of SMARCB1 in AML associates with SWI/SNFΔ nucleation, which in turn promotes Rac GTPase GEF expression, Rac activation, migration, and survival of AML cells, highlighting SWI/SNFΔ downstream signaling as important molecular regulator in AML. Mol Cancer Res; 16(5); 791–804. ©2018 AACR.

[1]  David A. Williams,et al.  Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization , 2005, Nature Medicine.

[2]  Benjamin Haibe-Kains,et al.  Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis , 2013, Proceedings of the National Academy of Sciences.

[3]  O. Delattre,et al.  RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1. , 2008, Cancer research.

[4]  A. Sengupta,et al.  Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells. , 2012, Blood.

[5]  David A. Williams,et al.  Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo. , 2010, Blood.

[6]  Yi Zheng,et al.  Rho GTPases in hematopoiesis and hemopathies. , 2010, Blood.

[7]  David A. Williams,et al.  Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. , 2007, Cancer cell.

[8]  Łukasz M. Boryń,et al.  Transcriptional plasticity promotes primary and acquired resistance to BET inhibition , 2015, Nature.

[9]  David A. Williams,et al.  Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia. , 2011, Blood.

[10]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[11]  G. Crabtree,et al.  Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. , 2014, Blood.

[12]  A. Schäffer,et al.  Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes , 2017, Nature Genetics.

[13]  David A. Williams,et al.  Hematopoietic Cell Regulation by Rac1 and Rac2 Guanosine Triphosphatases , 2003, Science.

[14]  Ming Yu,et al.  Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation , 2013, Genes & development.

[15]  G. Crabtree,et al.  Understanding the Words of Chromatin Regulation , 2009, Cell.

[16]  P. Park,et al.  The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers , 2017, Nature Communications.

[17]  O. Abdel-Wahab,et al.  The role of mutations in epigenetic regulators in myeloid malignancies , 2012, Nature Reviews Cancer.

[18]  A. Sengupta,et al.  Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression , 2007, Leukemia.

[19]  S. Lowe,et al.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.

[20]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[21]  Shawn M. Gillespie,et al.  SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation , 2016, Nature Genetics.

[22]  Shawn M. Gillespie,et al.  Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. , 2017, Cell stem cell.

[23]  Pablo Tamayo,et al.  Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway , 2010, Nature Medicine.

[24]  Keji Zhao,et al.  Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. , 2011, Genome research.

[25]  David A. Williams,et al.  Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation, and survival. , 2012, Blood.

[26]  A. Hall,et al.  Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. , 2002, Genes & development.

[27]  Peter J. Park,et al.  Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters , 2013, Proceedings of the National Academy of Sciences.

[28]  J. Ranish,et al.  Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex. , 2017, Cell reports.

[29]  S. Orkin,et al.  Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. , 2002, Cancer cell.

[30]  David A. Williams,et al.  Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis , 2008, Leukemia.

[31]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[32]  C. Haferlach,et al.  Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms , 2017, Leukemia.

[33]  S. Kulkarni,et al.  Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. , 1999, Cancer research.

[34]  C. Roberts,et al.  Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. , 2009, Cancer research.

[35]  G. Sauvageau,et al.  SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanism , 2017, Nature Genetics.

[36]  G. Crabtree,et al.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy , 2013, Nature Genetics.

[37]  D. Small,et al.  DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells , 2014, Leukemia.

[38]  Wai Lim Ku,et al.  SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters , 2017, Nature Genetics.

[39]  Nathan D. VanderKraats,et al.  DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML , 2014, Genome Biology.

[40]  B. Aronow,et al.  p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche. , 2014, Cell reports.

[41]  J. Krosl,et al.  A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. , 2010, Blood.

[42]  C. Roberts,et al.  Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Gunzer,et al.  Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. , 2012, Cell stem cell.

[44]  Alexey I Nesvizhskii,et al.  An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency , 2009, Proceedings of the National Academy of Sciences.

[45]  A. Sengupta,et al.  KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia. , 2017, Experimental hematology.

[46]  A. Durán,et al.  Atypical protein kinase C (aPKCζ and aPKCλ) is dispensable for mammalian hematopoietic stem cell activity and blood formation , 2011, Proceedings of the National Academy of Sciences.

[47]  H. Kestler,et al.  A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing , 2013, Nature.

[48]  G. Crabtree,et al.  The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function. , 2012, Blood.

[49]  J. Moss,et al.  Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling , 2012, Proceedings of the National Academy of Sciences.

[50]  N. Socci,et al.  Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. , 2012, The New England journal of medicine.